PubRank

Bart Maes

Author PubWeight™ 52.70‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet 2003 4.19
2 Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transplant 2004 1.75
3 Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients. Am J Transplant 2004 1.54
4 Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study). Eur Radiol 2012 1.42
5 Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure. Nephrol Dial Transplant 2004 1.38
6 Gastrointestinal side effects of mycophenolic acid in renal transplant patients: a reappraisal. Nephrol Dial Transplant 2007 1.30
7 Nonadherence with diet and fluid restrictions among adults having hemodialysis. J Nurs Scholarsh 2005 1.22
8 Risk factors for cardiovascular events after successful renal transplantation. Transplantation 2008 1.21
9 Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial. Am J Kidney Dis 2009 1.18
10 Long-term efficacy and tolerability of lanthanum carbonate: results from a 3-year study. Nephron Clin Pract 2005 1.15
11 Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacokinetics in de novo renal allograft recipients. Clin Pharmacol Ther 2004 1.12
12 Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study. Am J Kidney Dis 2005 1.08
13 Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients. Clin Pharmacokinet 2004 1.06
14 Predicting renal graft failure using multivariate longitudinal profiles. Biostatistics 2007 1.05
15 A pilot study on the use of the humanized anti-interleukin-2 receptor antibody daclizumab in active ulcerative colitis. Am J Gastroenterol 2003 1.03
16 Inflammation in renal transplantation. Clin J Am Soc Nephrol 2009 0.99
17 Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study. Nephrol Dial Transplant 2005 0.97
18 Genotypic drug resistance interpretation algorithms display high levels of discordance when applied to non-B strains from HIV-1 naive and treated patients. FEMS Immunol Med Microbiol 2006 0.97
19 Magnetic resonance imaging of non-tropical chyluria due to distal thoracic duct obstruction. Nephrol Dial Transplant 2004 0.92
20 Detoxifying capacity and kinetics of prometheus--a new extracorporeal system for the treatment of liver failure. Blood Purif 2005 0.92
21 Performance of the VERSANT HIV-1 resistance assays (LiPA) for detecting drug resistance in therapy-naive patients infected with different HIV-1 subtypes. FEMS Immunol Med Microbiol 2003 0.90
22 C3D deposition in peritubular capillaries indicates a variant of acute renal allograft rejection characterized by a worse clinical outcome. Transplantation 2003 0.88
23 fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study. Am J Transplant 2004 0.88
24 A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy. Nephrol Dial Transplant 2004 0.88
25 Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial. Transplantation 2005 0.87
26 Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial. Kidney Int 2004 0.87
27 A young patient with unexplained acute hepatorenal dysfunction. Nephrol Dial Transplant 2003 0.86
28 Detoxifying capacity and kinetics of the molecular adsorbent recycling system. Contribution of the different inbuilt filters. Blood Purif 2003 0.86
29 Cytochrome P450 3A4 and P-glycoprotein activity and assimilation of tacrolimus in transplant patients with persistent diarrhea. Am J Transplant 2005 0.86
30 Transiently positive hepatitis B surface antigen after vaccination with the new hepatitis B vaccine HBV-AS04. Am J Kidney Dis 2008 0.85
31 A new electronic monitoring device to measure medication adherence: usability of the Helping Hand™. Sensors (Basel) 2010 0.84
32 Acute-onset, steroid-sensitive, encapsulating peritoneal sclerosis in a renal transplant recipient. Am J Kidney Dis 2005 0.84
33 Two-tier approach for the detection of alpha-galactosidase A deficiency in a predominantly female haemodialysis population. Nephrol Dial Transplant 2007 0.84
34 Combined 'en bloc' liver and pancreas transplantation in patients with liver disease and type 1 diabetes mellitus. Am J Transplant 2004 0.83
35 Functional beta-cell mass and insulin sensitivity is decreased in insulin-independent pancreas-kidney recipients. Transplantation 2009 0.83
36 A prospective, randomized, double-blind crossover study on the use of 5% citrate lock versus 10% citrate lock in permanent hemodialysis catheters. Blood Purif 2005 0.82
37 Recessive type of nephrogenic diabetes insipidus. Am J Kidney Dis 2003 0.82
38 Cerebrovascular events in renal transplant recipients. Transplantation 2009 0.82
39 Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation. Nephrol Dial Transplant 2005 0.81
40 Beta-cell transplantation restores metabolic control and quality of life in a patient with subcutaneous insulin resistance. Diabetes Care 2004 0.80
41 Two-tier approach for the detection of alpha-galactosidase A deficiency in kidney transplant recipients. Nephrol Dial Transplant 2008 0.80
42 Regional citrate anticoagulation for hemodialysis using a conventional calcium-containing dialysate. Am J Kidney Dis 2002 0.80
43 Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts. Transplantation 2008 0.80
44 Successful conversion from cyclosporine to tacrolimus for gastric motor dysfunction in a lung transplant recipient. Transplantation 2002 0.78
45 Osteolysis induced by AV-fistula in idiopathic carpotarsal osteolysis. Nephrol Dial Transplant 2003 0.78
46 Renal dysfunction as a risk factor for mortality and cardiovascular disease in renal transplantation: experience from the Assessment of Lescol in Renal Transplantation trial. Transplantation 2005 0.78
47 Drug interaction between itraconazole and sirolimus in a primary renal allograft recipient. Transplantation 2005 0.77
48 Reflex sympathetic dystrophy in a renal transplant patient treated with sirolimus. Nephrol Dial Transplant 2007 0.77
49 Secondary effects of immunosuppressive drugs after simultaneous pancreas-kidney transplantation. Nephrol Dial Transplant 2005 0.77
50 Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response. J Acquir Immune Defic Syndr 2004 0.76
51 Mycophenolate sodium does not reduce the incidence of GI adverse events compared with mycophenolate mofetil. Am J Transplant 2005 0.75
52 MYSS: should we alter clinical practice? Lancet 2004 0.75
53 13C-breath tests in peritoneal dialysis patients: influence of dialysis fluids. Eur J Gastroenterol Hepatol 2003 0.75
54 Kidney transplantation with rabbit antithymocyte globulin and sirolimus monotherapy. Lancet 2003 0.75
55 An uncommon tumor in a renal graft recipient: a diagnostic and therapeutic challenge. Am J Kidney Dis 2002 0.75
56 Triangular face and vascular malformation. The links to renal failure. Nephrol Dial Transplant 2003 0.75
57 A simplified strategy for clinical management of late cytomegalovirus infection after oral ganciclovir prophylaxis in renal recipients. J Antimicrob Chemother 2005 0.75
58 Light chain deposition disease as a rare cause of restrictive cardiomyopathy. Acta Cardiol 2009 0.75
59 High anti-double-stranded DNA antibodies and progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus. Nephrol Dial Transplant 2005 0.75
60 A combination of poor adherence and a low baseline susceptibility score is highly predictive for HAART failure. Antivir Chem Chemother 2002 0.75